Analyze Diet
Tissue engineering. Part A2013; 19(9-10); 1100-1112; doi: 10.1089/ten.TEA.2012.0497

Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds.

Abstract: Biomolecular environments encountered in vivo are complex and dynamic, with combinations of biomolecules presented in both freely diffusible (liquid-phase) and sequestered (bound to the extracellular matrix) states. Strategies for integrating multiple biomolecular signals into a biomimetic scaffold provide a platform to simultaneously control multiple cell activities, such as motility, proliferation, phenotype, and regenerative potential. Here we describe an investigation elucidating the influence of the dose and mode of presentation (soluble, sequestered) of five biomolecules (stromal cell-derived factor 1α [SDF-1α], platelet-derived growth factor BB [PDGF-BB], insulin-like growth factor 1 [IGF-1], basic fibroblast growth factor [bFGF], and growth/differentiation factor 5 [GDF-5]) on the recruitment, proliferation, collagen synthesis, and genomic stability of equine tenocytes within an anisotropic collagen-GAG scaffold for tendon regeneration applications. Critically, we found that single factors led to a dose-dependent trade-off between driving tenocyte proliferation (PDGF-BB, IGF-1) versus maintenance of a tenocyte phenotype (GDF-5, bFGF). We identified supplementation schemes using factor pairs (IGF-1, GDF-5) to rescue the tenocyte phenotype and gene expression profiles while simultaneously driving proliferation. These results suggest coincident application of multi-biomolecule cocktails has a significant value in regenerative medicine applications where control of cell proliferation and phenotype are required. Finally, we demonstrated an immobilization strategy that allows efficient sequestration of bioactive levels of these factors within the scaffold network. We showed sequestration can lead to a greater sustained bioactivity than soluble supplementation, making this approach particularly amenable to in vivo translation where diffusive loss is a concern and continuous biomolecule supplementation is not feasible.
Publication Date: 2013-01-04 PubMed ID: 23157454PubMed Central: PMC3609632DOI: 10.1089/ten.TEA.2012.0497Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research addresses the development of biomimetic scaffolds that use combinations of biomolecules to control aspects of cell activity, specifically focusing on tenocytes. The aim is to advance tendon regeneration applications, by revealing how five biomolecules affect tenocyte bioactivity within a specially designed collagen-GAG scaffold, and finding optimal multi-biomolecule combinations and delivery methods.

Experiment design and objectives

  • The researchers sought to investigate how the dosage and mode of delivery (soluble or sequestered) of five biomolecules influence tenocyte activities. They used anisotropic collagen-GAG scaffolds in these experiments, which are designed for tendon regeneration.
  • The biomolecules investigated were stromal cell-derived factor 1α (SDF-1α), platelet-derived growth factor BB (PDGF-BB), insulin-like growth factor 1 (IGF-1), basic fibroblast growth factor (bFGF), and growth/differentiation factor 5 (GDF-5).
  • The aim was to understand the effect of these biomolecules on recruitment, proliferation, collagen synthesis, and genomic stability of equine tenocytes within the scaffolds.

Key Findings

  • Single biomolecules had a dose-dependent effect on tenocytes, with a trade-off between promoting tenocyte proliferation (PDGF-BB, IGF-1) and maintaining the tenocyte phenotype (GDF-5, bFGF). Essentially, certain factors promoted cell growth while others retained cell identity, but not both together.
  • By using dual supplementation schemes (IGF-1, GDF-5), the researchers were able to strike a balance between proliferation and phenotype maintenance. This showed that multi-biomolecule blends could significantly benefit regenerative medicine applications, particularly where cell proliferation and phenotype control are required.

Sequestration Strategy

  • The team also developed a strategy for immobilizing these biomolecules within the scaffold framework. This approach led to more sustained bioactivity than soluble supplementation, indicating its potential for in vivo applications.
  • This method of embedding biomolecules is valuable in real-world conditions where continuous biomolecule supplementation is not feasible and there are concerns about diffusive loss.

Impact on regenerative medicine

  • This study suggests that using a cocktail of biomolecules, rather than single factors, could significantly augment tissue regeneration efforts.
  • The findings also highlight the potential of scaffold sequestration as an effective biomolecule delivery method, which could make subsequent clinical application of these findings more feasible.

Cite This Article

APA
Caliari SR, Harley BA. (2013). Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds. Tissue Eng Part A, 19(9-10), 1100-1112. https://doi.org/10.1089/ten.TEA.2012.0497

Publication

ISSN: 1937-335X
NlmUniqueID: 101466659
Country: United States
Language: English
Volume: 19
Issue: 9-10
Pages: 1100-1112

Researcher Affiliations

Caliari, Steven R
  • Department of Chemical & Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Harley, Brendan A C

    MeSH Terms

    • Animals
    • Biomechanical Phenomena
    • Cell Proliferation / drug effects
    • Cells, Cultured
    • Chemokine CXCL12 / chemistry
    • Chemokine CXCL12 / pharmacology
    • Collagen / chemistry
    • Fibroblast Growth Factor 2 / chemistry
    • Fibroblast Growth Factor 2 / pharmacology
    • Growth Differentiation Factor 5 / chemistry
    • Growth Differentiation Factor 5 / pharmacology
    • Horses
    • Insulin-Like Growth Factor I / chemistry
    • Insulin-Like Growth Factor I / pharmacology
    • Platelet-Derived Growth Factor / chemistry
    • Platelet-Derived Growth Factor / pharmacology
    • Tendons / cytology
    • Tissue Engineering / methods
    • Tissue Scaffolds / chemistry

    Grant Funding

    • T32 GM070421 / NIGMS NIH HHS
    • T32GM070421 / NIGMS NIH HHS

    References

    This article includes 66 references
    1. Butler DL, Juncosa-Melvin N, Boivin GP, Galloway MT, Shearn JT, Gooch C, Awad H. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation.. J Orthop Res 2008 Jan;26(1):1-9.
      pubmed: 17676628doi: 10.1002/jor.20456google scholar: lookup
    2. Liu Y, Ramanath HS, Wang DA. Tendon tissue engineering using scaffold enhancing strategies.. Trends Biotechnol 2008 Apr;26(4):201-9.
      pubmed: 18295915doi: 10.1016/j.tibtech.2008.01.003google scholar: lookup
    3. Xu Y, Murrell GA. The basic science of tendinopathy.. Clin Orthop Relat Res 2008 Jul;466(7):1528-38.
      pmc: PMC2505234pubmed: 18478310doi: 10.1007/s11999-008-0286-4google scholar: lookup
    4. James R, Kesturu G, Balian G, Chhabra AB. Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options.. J Hand Surg Am 2008 Jan;33(1):102-12.
      pubmed: 18261674doi: 10.1016/j.jhsa.2007.09.007google scholar: lookup
    5. Schoen DC. Injuries of the wrist.. Orthop Nurs 2005 Jul-Aug;24(4):304-7.
    6. Vitale MA, Vitale MG, Zivin JG, Braman JP, Bigliani LU, Flatow EL. Rotator cuff repair: an analysis of utility scores and cost-effectiveness.. J Shoulder Elbow Surg 2007 Mar-Apr;16(2):181-7.
      pubmed: 17399623doi: 10.1016/j.jse.2006.06.013google scholar: lookup
    7. Cole DW, Ginn TA, Chen GJ, Smith BP, Curl WW, Martin DF, Poehling GG. Cost comparison of anterior cruciate ligament reconstruction: autograft versus allograft.. Arthroscopy 2005 Jul;21(7):786-90.
      pubmed: 16012490doi: 10.1016/j.arthro.2005.04.102google scholar: lookup
    8. Gulotta LV, Rodeo SA. Emerging ideas: Evaluation of stem cells genetically modified with scleraxis to improve rotator cuff healing.. Clin Orthop Relat Res 2011 Oct;469(10):2977-80.
      pmc: PMC3171546pubmed: 21132407doi: 10.1007/s11999-010-1727-4google scholar: lookup
    9. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin.. Proc Natl Acad Sci U S A 1989 Feb;86(3):933-7.
      pmc: PMC286593pubmed: 2915988doi: 10.1073/pnas.86.3.933google scholar: lookup
    10. Harley BA, Spilker MH, Wu JW, Asano K, Hsu HP, Spector M, Yannas IV. Optimal degradation rate for collagen chambers used for regeneration of peripheral nerves over long gaps.. Cells Tissues Organs 2004;176(1-3):153-65.
      pubmed: 14745243doi: 10.1159/000075035google scholar: lookup
    11. Yannas I.V.. Tissue and Organ Regeneration in Adults. .
    12. Huang KF, Hsu WC, Chiu WT, Wang JY. Functional improvement and neurogenesis after collagen-GAG matrix implantation into surgical brain trauma.. Biomaterials 2012 Mar;33(7):2067-75.
    13. Harley B.A.C., Gibson L.J.. In vivo and in vitro applications of collagen-GAG scaffolds. Chem Eng J 2008;137:102.
    14. O'Brien FJ, Harley BA, Yannas IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds.. Biomaterials 2005 Feb;26(4):433-41.
    15. Duffy GP, McFadden TM, Byrne EM, Gill SL, Farrell E, O'Brien FJ. Towards in vitro vascularisation of collagen-GAG scaffolds.. Eur Cell Mater 2011 Jan 12;21:15-30.
      pubmed: 21225592doi: 10.22203/ecm.v021a02google scholar: lookup
    16. Farrell E, O'Brien FJ, Doyle P, Fischer J, Yannas I, Harley BA, O'Connell B, Prendergast PJ, Campbell VA. A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes.. Tissue Eng 2006 Mar;12(3):459-68.
      pubmed: 16579679doi: 10.1089/ten.2006.12.459google scholar: lookup
    17. Harley BA, Kim HD, Zaman MH, Yannas IV, Lauffenburger DA, Gibson LJ. Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions.. Biophys J 2008 Oct;95(8):4013-24.
      pmc: PMC2553126pubmed: 18621811doi: 10.1529/biophysj.107.122598google scholar: lookup
    18. Harley BA, Lynn AK, Wissner-Gross Z, Bonfield W, Yannas IV, Gibson LJ. Design of a multiphase osteochondral scaffold III: Fabrication of layered scaffolds with continuous interfaces.. J Biomed Mater Res A 2010 Mar 1;92(3):1078-93.
      pubmed: 19301263doi: 10.1002/jbm.a.32387google scholar: lookup
    19. Harley BA, Lynn AK, Wissner-Gross Z, Bonfield W, Yannas IV, Gibson LJ. Design of a multiphase osteochondral scaffold. II. Fabrication of a mineralized collagen-glycosaminoglycan scaffold.. J Biomed Mater Res A 2010 Mar 1;92(3):1066-77.
      pubmed: 19301274doi: 10.1002/jbm.a.32361google scholar: lookup
    20. Caliari SR, Ramirez MA, Harley BA. The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering.. Biomaterials 2011 Dec;32(34):8990-8.
    21. Caliari SR, Harley BA. The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity.. Biomaterials 2011 Aug;32(23):5330-40.
    22. Thomopoulos S, Harwood FL, Silva MJ, Amiel D, Gelberman RH. Effect of several growth factors on canine flexor tendon fibroblast proliferation and collagen synthesis in vitro.. J Hand Surg Am 2005 May;30(3):441-7.
      pubmed: 15925149doi: 10.1016/j.jhsa.2004.12.006google scholar: lookup
    23. Gulotta LV, Rodeo SA. Growth factors for rotator cuff repair.. Clin Sports Med 2009 Jan;28(1):13-23.
      pubmed: 19064162doi: 10.1016/j.csm.2008.09.002google scholar: lookup
    24. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing.. Sports Med 2003;33(5):381-94.
    25. Yoshikawa Y, Abrahamsson SO. Dose-related cellular effects of platelet-derived growth factor-BB differ in various types of rabbit tendons in vitro.. Acta Orthop Scand 2001 Jun;72(3):287-92.
      pubmed: 11480607doi: 10.1080/00016470152846646google scholar: lookup
    26. Abrahamsson SO, Lundborg G, Lohmander LS. Recombinant human insulin-like growth factor-I stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendon.. J Orthop Res 1991 Jul;9(4):495-502.
      pubmed: 2045976doi: 10.1002/jor.1100090405google scholar: lookup
    27. Costa MA, Wu C, Pham BV, Chong AK, Pham HM, Chang J. Tissue engineering of flexor tendons: optimization of tenocyte proliferation using growth factor supplementation.. Tissue Eng 2006 Jul;12(7):1937-43.
      pubmed: 16889523doi: 10.1089/ten.2006.12.1937google scholar: lookup
    28. Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells.. Biochem Biophys Res Commun 2007 May 11;356(3):780-4.
      pubmed: 17382293doi: 10.1016/j.bbrc.2007.03.049google scholar: lookup
    29. Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.. Stem Cells 2007 Jul;25(7):1737-45.
      pubmed: 17395768doi: 10.1634/stemcells.2007-0054google scholar: lookup
    30. Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H, Hamada T, Kato Y. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells.. Stem Cells Dev 2007 Feb;16(1):119-29.
      pubmed: 17348810doi: 10.1089/scd.2006.0032google scholar: lookup
    31. Schmidt A, Ladage D, Schinköthe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells.. Stem Cells 2006 Jul;24(7):1750-8.
      pubmed: 16822883doi: 10.1634/stemcells.2005-0191google scholar: lookup
    32. Ker ED, Chu B, Phillippi JA, Gharaibeh B, Huard J, Weiss LE, Campbell PG. Engineering spatial control of multiple differentiation fates within a stem cell population.. Biomaterials 2011 May;32(13):3413-22.
    33. Sahoo S, Toh SL, Goh JC. A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells.. Biomaterials 2010 Apr;31(11):2990-8.
    34. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.. Stem Cells 2006 May;24(5):1254-64.
      pubmed: 16410389doi: 10.1634/stemcells.2005-0271google scholar: lookup
    35. Du L, Yang P, Ge S. Stromal cell-derived factor-1 significantly induces proliferation, migration, and collagen type I expression in a human periodontal ligament stem cell subpopulation.. J Periodontol 2012 Mar;83(3):379-88.
      pubmed: 21749168doi: 10.1902/jop.2011.110201google scholar: lookup
    36. Shen W, Chen X, Chen J, Yin Z, Heng BC, Chen W, Ouyang HW. The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration.. Biomaterials 2010 Oct;31(28):7239-49.
    37. Park A, Hogan MV, Kesturu GS, James R, Balian G, Chhabra AB. Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers.. Tissue Eng Part A 2010 Sep;16(9):2941-51.
      pmc: PMC2928041pubmed: 20575691doi: 10.1089/ten.tea.2009.0710google scholar: lookup
    38. Keller TC, Hogan MV, Kesturu G, James R, Balian G, Chhabra AB. Growth/differentiation factor-5 modulates the synthesis and expression of extracellular matrix and cell-adhesion-related molecules of rat Achilles tendon fibroblasts.. Connect Tissue Res 2011;52(4):353-64.
      pubmed: 21250863doi: 10.3109/03008207.2010.534208google scholar: lookup
    39. James R, Kumbar SG, Laurencin CT, Balian G, Chhabra AB. Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems.. Biomed Mater 2011 Apr;6(2):025011.
    40. Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ, Wozney JM, Rosen V. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family.. J Clin Invest 1997 Jul 15;100(2):321-30.
      pmc: PMC508194pubmed: 9218508doi: 10.1172/jci119537google scholar: lookup
    41. Liu HW, Chen CH, Tsai CL, Hsiue GH. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.. Bone 2006 Oct;39(4):825-36.
      pubmed: 16782421doi: 10.1016/j.bone.2006.04.027google scholar: lookup
    42. Shen YH, Shoichet MS, Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells.. Acta Biomater 2008 May;4(3):477-89.
      pubmed: 18328795doi: 10.1016/j.actbio.2007.12.011google scholar: lookup
    43. Oh SH, Kim TH, Lee JH. Creating growth factor gradients in three dimensional porous matrix by centrifugation and surface immobilization.. Biomaterials 2011 Nov;32(32):8254-60.
    44. Anderson SM, Chen TT, Iruela-Arispe ML, Segura T. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF.. Biomaterials 2009 Sep;30(27):4618-28.
    45. Martin TA, Caliari SR, Williford PD, Harley BA, Bailey RC. The generation of biomolecular patterns in highly porous collagen-GAG scaffolds using direct photolithography.. Biomaterials 2011 Jun;32(16):3949-57.
    46. O'Brien FJ, Harley BA, Yannas IV, Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds.. Biomaterials 2004 Mar;25(6):1077-86.
      pubmed: 14615173doi: 10.1016/s0142-9612(03)00630-6google scholar: lookup
    47. Caliari SR, Weisgerber DW, Ramirez MA, Kelkhoff DO, Harley BA. The influence of collagen-glycosaminoglycan scaffold relative density and microstructural anisotropy on tenocyte bioactivity and transcriptomic stability.. J Mech Behav Biomed Mater 2012 Jul;11:27-40.
      pmc: PMC3947516pubmed: 22658152doi: 10.1016/j.jmbbm.2011.12.004google scholar: lookup
    48. Olde Damink LH, Dijkstra PJ, van Luyn MJ, van Wachem PB, Nieuwenhuis P, Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide.. Biomaterials 1996 Apr;17(8):765-73.
      pubmed: 8730960doi: 10.1016/0142-9612(96)81413-xgoogle scholar: lookup
    49. Harley BA, Leung JH, Silva EC, Gibson LJ. Mechanical characterization of collagen-glycosaminoglycan scaffolds.. Acta Biomater 2007 Jul;3(4):463-74.
      pubmed: 17349829doi: 10.1016/j.actbio.2006.12.009google scholar: lookup
    50. Kapoor A, Caporali EH, Kenis PJ, Stewart MC. Microtopographically patterned surfaces promote the alignment of tenocytes and extracellular collagen.. Acta Biomater 2010 Jul;6(7):2580-9.
      pubmed: 20045087doi: 10.1016/j.actbio.2009.12.047google scholar: lookup
    51. Freyman T.M., Yannas I.V., Gibson L.J.. Cellular materials as porous scaffolds for tissue engineering. Prog Mater Sci 2001;46:273.
    52. Odedra D, Chiu LL, Shoichet M, Radisic M. Endothelial cells guided by immobilized gradients of vascular endothelial growth factor on porous collagen scaffolds.. Acta Biomater 2011 Aug;7(8):3027-35.
      pubmed: 21601017doi: 10.1016/j.actbio.2011.05.002google scholar: lookup
    53. Gibson L.J., Ashby M.F., Harley B.A.. Cellular Materials in Nature and Medicine. .
    54. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay of DNA in cartilage explants using Hoechst 33258.. Anal Biochem 1988 Oct;174(1):168-76.
      pubmed: 2464289doi: 10.1016/0003-2697(88)90532-5google scholar: lookup
    55. Tierney CM, Jaasma MJ, O'Brien FJ. Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations.. J Biomed Mater Res A 2009 Oct;91(1):92-101.
      pubmed: 18767061doi: 10.1002/jbm.a.32207google scholar: lookup
    56. Taylor SE, Vaughan-Thomas A, Clements DN, Pinchbeck G, Macrory LC, Smith RK, Clegg PD. Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems.. BMC Musculoskelet Disord 2009 Feb 26;10:27.
      pmc: PMC2651848pubmed: 19245707doi: 10.1186/1471-2474-10-27google scholar: lookup
    57. Wagenhäuser MU, Pietschmann MF, Sievers B, Docheva D, Schieker M, Jansson V, Müller PE. Collagen type I and decorin expression in tenocytes depend on the cell isolation method.. BMC Musculoskelet Disord 2012 Aug 8;13:140.
      pmc: PMC3518183pubmed: 22871215doi: 10.1186/1471-2474-13-140google scholar: lookup
    58. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.. Blood 2004 Nov 1;104(9):2643-5.
      pubmed: 15251986doi: 10.1182/blood-2004-02-0526google scholar: lookup
    59. Pek YS, Spector M, Yannas IV, Gibson LJ. Degradation of a collagen-chondroitin-6-sulfate matrix by collagenase and by chondroitinase.. Biomaterials 2004 Feb;25(3):473-82.
      pubmed: 14585696doi: 10.1016/s0142-9612(03)00541-6google scholar: lookup
    60. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression.. J Orthop Res 2009 Aug;27(8):1033-42.
      pubmed: 19170097doi: 10.1002/jor.20853google scholar: lookup
    61. Halász K, Kassner A, Mörgelin M, Heinegård D. COMP acts as a catalyst in collagen fibrillogenesis.. J Biol Chem 2007 Oct 26;282(43):31166-73.
      pubmed: 17716974doi: 10.1074/jbc.m705735200google scholar: lookup
    62. Yoon JH, Halper J. Tendon proteoglycans: biochemistry and function.. J Musculoskelet Neuronal Interact 2005 Mar;5(1):22-34.
      pubmed: 15788868
    63. Liu CF, Aschbacher-Smith L, Barthelery NJ, Dyment N, Butler D, Wylie C. Spatial and temporal expression of molecular markers and cell signals during normal development of the mouse patellar tendon.. Tissue Eng Part A 2012 Mar;18(5-6):598-608.
      pmc: PMC3286855pubmed: 21939397doi: 10.1089/ten.tea.2011.0338google scholar: lookup
    64. Kuo CK, Tuan RS. Mechanoactive tenogenic differentiation of human mesenchymal stem cells.. Tissue Eng Part A 2008 Oct;14(10):1615-27.
      pubmed: 18759661doi: 10.1089/ten.tea.2006.0415google scholar: lookup
    65. Riley GP, Harrall RL, Cawston TE, Hazleman BL, Mackie EJ. Tenascin-C and human tendon degeneration.. Am J Pathol 1996 Sep;149(3):933-43.
      pmc: PMC1865170pubmed: 8780397
    66. Doroski DM, Levenston ME, Temenoff JS. Cyclic tensile culture promotes fibroblastic differentiation of marrow stromal cells encapsulated in poly(ethylene glycol)-based hydrogels.. Tissue Eng Part A 2010 Nov;16(11):3457-66.
      pmc: PMC2965196pubmed: 20666585doi: 10.1089/ten.tea.2010.0233google scholar: lookup

    Citations

    This article has been cited 34 times.
    1. Tsiapalis D, Kearns S, Kelly JL, Zeugolis DI. Growth factor and macromolecular crowding supplementation in human tenocyte culture.. Biomater Biosyst 2021 Mar;1:100009.
      doi: 10.1016/j.bbiosy.2021.100009pubmed: 36825160google scholar: lookup
    2. Miescher I, Rieber J, Calcagni M, Buschmann J. In Vitro and In Vivo Effects of IGF-1 Delivery Strategies on Tendon Healing: A Review.. Int J Mol Sci 2023 Jan 25;24(3).
      doi: 10.3390/ijms24032370pubmed: 36768692google scholar: lookup
    3. Shiroud Heidari B, Ruan R, Vahabli E, Chen P, De-Juan-Pardo EM, Zheng M, Doyle B. Natural, synthetic and commercially-available biopolymers used to regenerate tendons and ligaments.. Bioact Mater 2023 Jan;19:179-197.
    4. Chen CH, Li DL, Chuang AD, Dash BS, Chen JP. Tension Stimulation of Tenocytes in Aligned Hyaluronic Acid/Platelet-Rich Plasma-Polycaprolactone Core-Sheath Nanofiber Membrane Scaffold for Tendon Tissue Engineering.. Int J Mol Sci 2021 Oct 18;22(20).
      doi: 10.3390/ijms222011215pubmed: 34681872google scholar: lookup
    5. Ryan CNM, Pugliese E, Shologu N, Gaspar D, Rooney P, Islam MN, O'Riordan A, Biggs MJ, Griffin MD, Zeugolis DI. A combined physicochemical approach towards human tenocyte phenotype maintenance.. Mater Today Bio 2021 Sep;12:100130.
      doi: 10.1016/j.mtbio.2021.100130pubmed: 34632361google scholar: lookup
    6. Williamson PM, Freedman BR, Kwok N, Beeram I, Pennings J, Johnson J, Hamparian D, Cohen E, Galloway JL, Ramappa AJ, DeAngelis JP, Nazarian A. Tendinopathy and tendon material response to load: What we can learn from small animal studies.. Acta Biomater 2021 Oct 15;134:43-56.
      doi: 10.1016/j.actbio.2021.07.046pubmed: 34325074google scholar: lookup
    7. Tiffany AS, Dewey MJ, Harley BAC. Sequential sequestrations increase the incorporation and retention of multiple growth factors in mineralized collagen scaffolds.. RSC Adv 2020;10(45):26982-26996.
      doi: 10.1039/d0ra03872epubmed: 33767853google scholar: lookup
    8. Li Z, Xiang S, Li EN, Fritch MR, Alexander PG, Lin H, Tuan RS. Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling.. Handb Exp Pharmacol 2021;265:235-268.
      doi: 10.1007/164_2020_377pubmed: 33471201google scholar: lookup
    9. Dewey MJ, Nosatov AV, Subedi K, Harley B. Anisotropic mineralized collagen scaffolds accelerate osteogenic response in a glycosaminoglycan-dependent fashion.. RSC Adv 2020;10(26):15629-15641.
      doi: 10.1039/D0RA01336Fpubmed: 32655857google scholar: lookup
    10. Shojaee A, Parham A. Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.. Stem Cell Res Ther 2019 Jun 18;10(1):181.
      doi: 10.1186/s13287-019-1291-0pubmed: 31215490google scholar: lookup
    11. Rajpar I, Barrett JG. Optimizing growth factor induction of tenogenesis in three-dimensional culture of mesenchymal stem cells.. J Tissue Eng 2019 Jan-Dec;10:2041731419848776.
      doi: 10.1177/2041731419848776pubmed: 31205672google scholar: lookup
    12. Hortensius RA, Ebens JH, Dewey MJ, Harley BAC. Incorporation of the Amniotic Membrane as an Immunomodulatory Design Element in Collagen Scaffolds for Tendon Repair.. ACS Biomater Sci Eng 2018 Dec 10;4(12):4367-4377.
    13. Walia B, Huang AH. Tendon stem progenitor cells: Understanding the biology to inform therapeutic strategies for tendon repair.. J Orthop Res 2019 Jun;37(6):1270-1280.
      doi: 10.1002/jor.24156pubmed: 30270569google scholar: lookup
    14. Grier WK, Tiffany AS, Ramsey MD, Harley BAC. Incorporating β-cyclodextrin into collagen scaffolds to sequester growth factors and modulate mesenchymal stem cell activity.. Acta Biomater 2018 Aug;76:116-125.
      doi: 10.1016/j.actbio.2018.06.033pubmed: 29944975google scholar: lookup
    15. Baldwin M, Snelling S, Dakin S, Carr A. Augmenting endogenous repair of soft tissues with nanofibre scaffolds.. J R Soc Interface 2018 Apr;15(141).
      doi: 10.1098/rsif.2018.0019pubmed: 29695606google scholar: lookup
    16. Li J, Weber E, Guth-Gundel S, Schuleit M, Kuttler A, Halleux C, Accart N, Doelemeyer A, Basler A, Tigani B, Wuersch K, Fornaro M, Kneissel M, Stafford A, Freedman BR, Mooney DJ. Tough Composite Hydrogels with High Loading and Local Release of Biological Drugs.. Adv Healthc Mater 2018 May;7(9):e1701393.
      doi: 10.1002/adhm.201701393pubmed: 29441702google scholar: lookup
    17. Musson DS, Tay ML, Chhana A, Pool B, Coleman B, Naot D, Cornish J. Lactoferrin and parathyroid hormone are not harmful to primary tenocytes in vitro, but PDGF may be.. Muscles Ligaments Tendons J 2017 Apr-Jun;7(2):215-222.
      doi: 10.11138/mltj/2017.7.2.215pubmed: 29264331google scholar: lookup
    18. Viganò M, Perucca Orfei C, Colombini A, Stanco D, Randelli P, Sansone V, de Girolamo L. Different culture conditions affect the growth of human tendon stem/progenitor cells (TSPCs) within a mixed tendon cells (TCs) population.. J Exp Orthop 2017 Dec;4(1):8.
      doi: 10.1186/s40634-017-0082-8pubmed: 28244027google scholar: lookup
    19. Farnebo S, Farnebo L, Kim M, Woon C, Pham H, Chang J. Optimized Repopulation of Tendon Hydrogel: Synergistic Effects of Growth Factor Combinations and Adipose-Derived Stem Cells.. Hand (N Y) 2017 Jan;12(1):68-77.
      doi: 10.1177/1558944715628005pubmed: 28082847google scholar: lookup
    20. Grier WK, Iyoha EM, Harley BAC. The influence of pore size and stiffness on tenocyte bioactivity and transcriptomic stability in collagen-GAG scaffolds.. J Mech Behav Biomed Mater 2017 Jan;65:295-305.
      doi: 10.1016/j.jmbbm.2016.08.034pubmed: 27614271google scholar: lookup
    21. Mozdzen LC, Rodgers R, Banks JM, Bailey RC, Harley BA. Increasing the strength and bioactivity of collagen scaffolds using customizable arrays of 3D-printed polymer fibers.. Acta Biomater 2016 Mar;33:25-33.
      doi: 10.1016/j.actbio.2016.02.004pubmed: 26850145google scholar: lookup
    22. Hortensius RA, Ebens JH, Harley BA. Immunomodulatory effects of amniotic membrane matrix incorporated into collagen scaffolds.. J Biomed Mater Res A 2016 Jun;104(6):1332-42.
      doi: 10.1002/jbm.a.35663pubmed: 26799369google scholar: lookup
    23. Mahadik BP, Pedron Haba S, Skertich LJ, Harley BA. The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel.. Biomaterials 2015 Oct;67:297-307.
    24. Hortensius RA, Becraft JR, Pack DW, Harley BA. The effect of glycosaminoglycan content on polyethylenimine-based gene delivery within three-dimensional collagen-GAG scaffolds.. Biomater Sci 2015 Apr;3(4):645-54.
      doi: 10.1039/C5BM00033Epubmed: 26097698google scholar: lookup
    25. Pence JC, Clancy KB, Harley BA. The induction of pro-angiogenic processes within a collagen scaffold via exogenous estradiol and endometrial epithelial cells.. Biotechnol Bioeng 2015 Oct;112(10):2185-94.
      doi: 10.1002/bit.25622pubmed: 25944769google scholar: lookup
    26. Weisgerber DW, Caliari SR, Harley BA. Mineralized collagen scaffolds induce hMSC osteogenesis and matrix remodeling.. Biomater Sci 2015 Mar;3(3):533-42.
      doi: 10.1039/C4BM00397Gpubmed: 25937924google scholar: lookup
    27. Nourissat G, Berenbaum F, Duprez D. Tendon injury: from biology to tendon repair.. Nat Rev Rheumatol 2015 Apr;11(4):223-33.
      doi: 10.1038/nrrheum.2015.26pubmed: 25734975google scholar: lookup
    28. Caliari SR, Weisgerber DW, Grier WK, Mahmassani Z, Boppart MD, Harley BA. Collagen Scaffolds Incorporating Coincident Gradations of Instructive Structural and Biochemical Cues for Osteotendinous Junction Engineering.. Adv Healthc Mater 2015 Apr 22;4(6):831-7.
      doi: 10.1002/adhm.201400809pubmed: 25597299google scholar: lookup
    29. Pence JC, Gonnerman EA, Bailey RC, Harley BA. Strategies to balance covalent and non-covalent biomolecule attachment within collagen-GAG biomaterials.. Biomater Sci 2014 Sep 1;2(9):1296-1304.
      doi: 10.1039/C4BM00193Apubmed: 25147727google scholar: lookup
    30. Banks JM, Mozdzen LC, Harley BA, Bailey RC. The combined effects of matrix stiffness and growth factor immobilization on the bioactivity and differentiation capabilities of adipose-derived stem cells.. Biomaterials 2014 Oct;35(32):8951-9.
    31. Caliari SR, Gonnerman EA, Grier WK, Weisgerber DW, Banks JM, Alsop AJ, Lee JS, Bailey RC, Harley BA. Collagen scaffold arrays for combinatorial screening of biophysical and biochemical regulators of cell behavior.. Adv Healthc Mater 2015 Jan 7;4(1):58-64.
      doi: 10.1002/adhm.201400252pubmed: 24989480google scholar: lookup
    32. Caliari SR, Harley BA. Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation.. Adv Healthc Mater 2014 Jul;3(7):1086-96.
      doi: 10.1002/adhm.201300646pubmed: 24574180google scholar: lookup
    33. Caliari SR, Mozdzen LC, Armitage O, Oyen ML, Harley BA. Award Winner in the Young Investigator Category, 2014 Society for Biomaterials Annual Meeting and Exposition, Denver, Colorado, April 16-19, 2014: Periodically perforated core-shell collagen biomaterials balance cell infiltration, bioactivity, and mechanical properties.. J Biomed Mater Res A 2014 Apr;102(4):917-27.
      doi: 10.1002/jbm.a.35058pubmed: 24327556google scholar: lookup
    34. Hortensius RA, Harley BA. The use of bioinspired alterations in the glycosaminoglycan content of collagen-GAG scaffolds to regulate cell activity.. Biomaterials 2013 Oct;34(31):7645-52.